66 Recruiting NSCLC Clinical Trials
Explore open interventional and observational research studies actively enrolling participants across the USA. Verify eligibility and contact site coordinators directly.
📍 Find Near Me by DistanceBrowse by State
Browse by Study Phase
Top Interventions for NSCLC
Related Conditions
Top Recruiting NSCLC Studies
Comparing Single vs Multiple Dose Radiation for Cancer Patients With Brain Metastasis and Receiving Immunotherapy
📍 Lewis Cancer and Research Pavilion at Saint Joseph's/Candler — Savannah, Georgia
View Study & Checklist ➔A Phase 2 Study of EIK1001 in Combo With Pembrolizumab and Chemotherapy in Patients With Stage 4 NSCLC
📍 Southern Cancer Care — Daphne, Alabama
View Study & Checklist ➔Atezolizumab Immunotherapy With or Without Tiragolumab for Patients With Unresectable Stage III NSCLC
📍 University of California San Diego Moores Cancer Center — La Jolla, California
View Study & Checklist ➔A Prospective Study of Plasma Genotyping as a Noninvasive Biomarker for Genotype-directed Cancer Care
📍 Dana-Farber Cancer Institute — Boston, Massachusetts
View Study & Checklist ➔Study of Oral MRT-2359 in Selected Cancer Patients
📍 Honor Health Research Institute — Scottsdale, Arizona
View Study & Checklist ➔Phase III, Open-label, First-line Study of Dato-DXd in Combination With Durvalumab and Carboplatin for Advanced NSCLC Without Actionable Genomic Alterations
📍 Research Site — Phoenix, Arizona
View Study & Checklist ➔An Observational Study to Evaluate the Real-World Clinical Management and Outcomes of ALK-Positive Advanced NSCLC Participants Treated With Alectinib
📍 Clinica Adventista Belgrano — Ciudad Autonoma Buenos Aires,
View Study & Checklist ➔Treating Early-stage Non-Small Cell Lung Cancer With Durvalumab and Radiation Therapy
📍 Baptist Alliance - McI — Miami, Florida
View Study & Checklist ➔A Phase 1/2 Study of BA3071 in Patients With Solid Tumors
📍 The Angeles Clinic and Research Institute — Los Angeles, California
View Study & Checklist ➔Neoadjuvant Platform Trial in Non-Small Cell Lung Cancer
📍 CancerCare Manitoba — Winnipeg, Manitoba
View Study & Checklist ➔Pre-operative Tumor Treating Fields in Patients With Resectable Lung Cancer
📍 The University of Texas Southwestern Medical Center — Dallas, Texas
View Study & Checklist ➔LUNG-05: Investigating Chemotherapy Effectiveness for Non-Small Cell Lung Cancer (NSCLC) Metastatic Patients
📍 University of Illinois Cancer Center — Chicago, Illinois
View Study & Checklist ➔A Study of EP0031 (Lunbotinib) in Patients With Advanced RET-altered Malignancies
📍 David Geffen School of Medicine at UCLA — Los Angeles, California
View Study & Checklist ➔A Study of BIO 300 and Thoracic Radiation Therapy in People With Non-Small Cell Lung Cancer and Interstitial Lung Disease
📍 Memorial Sloan Kettering Basking Ridge (Limited Protocol Activities) — Basking Ridge, New Jersey
View Study & Checklist ➔Thoracic Radiotherapy and Inhibition of PD-1 and LAG-3 for Locally Advanced Non-Small Cell Lung Cancer
📍 Montefiore Einstein Comprehensive Cancer Center (MECCC) — The Bronx, New York
View Study & Checklist ➔A Study of REGN5093 in Adult Patients With Mesenchymal Epithelial Transition Factor (MET)-Altered Advanced Non-Small Cell Lung Cancer
📍 University of Alabama at Birmingham — Birmingham, Alabama
View Study & Checklist ➔Study of Pembrolizumab + Pemetrexed + Platinum Chemotherapy With or Without Zoldonrasib as First Line Treatment in Metastatic Non-squamous RAS G12D-Mutated NSCLC
📍 Florida Clinical Trials Group, LLC — Plantation, Florida
View Study & Checklist ➔Safety, Tolerability, and Preliminary Efficacy of CJRB-101 With Pembrolizumab in Subjects With Selected Types of Advanced or Metastatic Cancer
📍 University of California, Irvine — Irvine, California
View Study & Checklist ➔